Skip to main content Accessibility help
  • Print publication year: 2015
  • Online publication date: April 2015

172 - Candidiasis

from Part XXII - Specific organisms: fungi
Suggested reading
Andes, DR, Safdar, N, Baddley, JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54:1110–1122.
Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59(RR-12):1–110.
Gafter-Gvili, A, Vidal, L, Goldberg, E, Leibovici, L, Paul, M. Treatment of invasive candidal infections: systematic review and meta-analysis. Mayo Clin Proc. 2008;83:1011–1021.
Ilkit, M, Guzel, AB. The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective. Crit Rev Microbiol. 2011;37:250–261.
Kaplan, JE, Benson, C, Holmes, KK, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents; recommendations from the CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Disease Society of America. MMWR Recomm Rep. 2009;58(RR-4):1–198.
Karageorgopoulos, DE, Vouloumanou, EK, Ntziora, F, et al. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis. 2011;52:750–770.
Kim, J, Sudbery, P.Candida albicans, a major human fungal pathogen. J Microbiol. 2011;49:171–177.
Pappas, PG. Invasive candidiasis. Infect Dis Clin North Am. 2006;20(3):485–506.
Pappas, PG, Rex, JH, Sobel, JD, et al. Clinical practice guidelines for the management of candidiasis. Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–535.